Outcome of patients with buruli ulcer after surgical treatment with or without antimycobacterial treatment in Ghana

American Journal of Tropical Medicine and Hygiene

Volumn 81, Issue 1, 2009, Pages 75-81

  Schunk, Mirjam ^a   Thompson, William ^b   Klutse, Erasmus ^c   Nitschke, Jörg ^d   Opare Asamoah, Kwame ^e   Thompson, Ruth ^e   Fleischmann, Erna ^a   Siegmund, Vera ^a   Herbinger, Karl Heinz ^a   Adjei, Ohene ^e   Fleischer, Bernhard ^d   Loscher, Thomas ^a   Bretzel, Gisela ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b Agogo Presbyterian Hospital   (Ghana)

^c Dunkwa Governmental Hospital   (Ghana)

^d BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

^e KUMASI CENTRE FOR COLLABORATIVE RESEARCH IN TROPICAL MEDICINE   (Ghana)

Author keywords

[No Author keywords available]

Indexed keywords

RIFAMPICIN; STREPTOMYCIN; ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; BURULI ULCER; CHILD; CLINICAL ASSESSMENT; CONTROLLED STUDY; DAILY LIFE ACTIVITY; FEMALE; FOLLOW UP; GHANA; HUMAN; JOINT MOBILITY; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRESCHOOL CHILD; RANGE OF MOTION; RECURRENCE RISK; RECURRENT DISEASE; RISK FACTOR; SCHOOL CHILD; SKIN TRANSPLANTATION; DRUG EFFECT; JOINT CHARACTERISTICS AND FUNCTIONS; MIDDLE AGED; MYCOBACTERIUM ULCERANS; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; BURULI ULCER; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYCOBACTERIUM ULCERANS; RANGE OF MOTION, ARTICULAR; RECURRENCE; TREATMENT OUTCOME;

EID: 67650284524     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2009.81.75     Document Type: Article

References (30)

1. World Health Organization, 2001. Buruli ulcer. Management of Mycobacterium ulcerans disease. Available at: http://www.whqlibdoc.who.int/hq/ 2001/WHO-CDS-CPE-GBU I-2001.3. pdf. Accessed August 26, 2008.
2. van der Werf TS, van der Graaf WT, Tappero JW, Asiedu K, 1999. Mycobacterium ulcerans infection. Lancet 354: 1013-1018.
3. World Health Organization, 2008. Buruli ulcer: progress report, 2004-2008. Wkly Epidemiol Rec 17: 145-156.
4. Amofah G, Bonsu F, Tetteh C, Okrah J, Asamoa K, Asiedu K, Addy J, 2002. Buruli ulcer in Ghana: results of a national case search. Emerg Infect Dis 8: 167-170. (Pubitemid 34202439)
5. Wansbrough-Jones M, Phillips R, 2006. Buruli ulcer: emerging from obscurity. Lancet 367: 1849-1858.
6. Portaels F, Elsen P, Guimaraes-Peres A, Fonteyne PA, Meyers WM, 1999. Insects in the transmission of Mycobacterium ulcerans infection. Lancet 353: 986. (Pubitemid 29132618)
7. Portaels F, Meyers WM, Ablordey A, Castro AG, 2008. First cultivation and characterization of Mycobacterium ulcerans from the environment. PLoS Negl Trop Dis 2: e178. (Pubitemid 352002936)
8. Pszolla N, Sarkar MR, Strecker W, Kern P, Kinzl L, Meyers WM, Portaels F, 2003. Buruli ulcer: a systemic disease. Clin Infect Dis 37: e78-e82.
9. Stienstra Y, Dijkstra PU, Guédénon A, Johnson RC, Ampadu EO, Mensah T, Klutse EY, Etuaful S, Deepak S, van der Graaf WT, van der Werf TS, 2004. Development of a questionnaire assessing Buruli ulcer-induced functional limitation. Am J Trop Med Hyg 70: 318-322. (Pubitemid 38366539)
10. Stienstra Y, Dijkstra PU, van Wezel MJ, van Roest MH, Beets M, Zijlstra I, Johnson RC, Ampadu EO, Gbovi J, Zinsou C, Etuaful S, Klutse EY, Van der Graaf WT, Van der Werf TS, 2005. Reliability and validity of the buruli ulcer functional limitation score questionnaire. Am J Trop Med Hyg 72: 449-452. (Pubitemid 41278856)
11. Stienstra Y, van Roest MHG, van Wezel MJ, Wiersma IC, Hospers IC, Dijkstra PU, Johnson RC, Ampadu EO, Gbovi J, Zinsou C, Etuaful S, Klutse EY, van der Graaf WT, van der Werf TS, 2005. Factors associated with functional limitations and subsequent employment or schooling in Buruli ulcer patients. Trop Med Int Health 10: 1251-1257. (Pubitemid 41789678)
12. World Health Organization, 2004. Provisional guidance on the role of antibiotics in the management of Mycobacterium ulcerans disease. Available at: http://www.who.int/entity/buruli/information/antibiotics/en/. Accessed August 26, 2008.
13. Etuaful S, Carbonnelle B, Grosset J, Lucas S, Horsfield C, Phillips R, Evans M, Ofori-Adjei D, Klustse E, Owusu-Boateng J, Amedofu GK, Awuah P, Ampadu E, Amofah G, Asiedu K, Wansbrough-Jones M, 2005. Efficacy of the combination rifampin-streptomycin in preventing growth of Mycobacterium ulcerans in early lesions of Buruli ulcer in humans. Antimicrob Agents Chemother 49: 3182-3186. (Pubitemid 41060558)
14. World Health Organization, 2001. Buruli ulcer: diagnosis of Mycobacterium ulcerans disease. Available at: http://whqlibdoc.who.int/hq/2001/WHO-CDS-CPE- GBUI-2001.4.pdf. Accessed August 26, 2008.
15. Bretzel G, Siegmund V, Nitschke J, Herbinger KH, Thompson W, Klutse E, Crofts K, Massavon W, Etuaful S, Thompson R, Asamoah-Opare K, Racz P, Vloten F, van Berberich C, Kruppa T, Ampadu E, Fleischer B, Adjei O, 2007. A step-wise approach to the laboratory diagnosis of Buruli ulcer disease. Trop Med Int Health 12: 89-96. (Pubitemid 44973858)
16. Gerhardt JJ, Rondinelli RD, 2001. Goniometric techniques for range-of-motion assessment. Phys Med Rehabil Clin N Am 12: 507-527.
17. World Health Organization, 2007. Summary report of the WHO annual meeting on Buruli Ulcer, 2-4 April 2007 and report of the technical advisory Group (TAG) meeting, 5 April, Geneva, 2007. Available at: http://www.who.int/buruli/ events/Report-2007-meeting-FINAL.pdf. Accessed August 26, 2008.
18. World Health Organization, 2008. Meeting of the WHO technical advisory group on Buruli ulcer 3 April 2008, Geneva, summary report. Available at: http://www.who.int/buruli/events/TAG-report-FINAL.pdf. Accessed August 26, 2008.
19. SAS Institute, 2006. SAS 9.1.3. SAS Institute, Cary, NC.
20. Bretzel G, Siegmund V, Racz P, van Vloten F, Ngos F, Thompson W, Biason P, Adjei O, Fleischer B, Nitschke J, 2005. Post-surgical assessment of excised tissue from patients with Buruli ulcer disease: progression of infection in macroscopically healthy tissue. Trop Med Int Health 10: 1199-1206. (Pubitemid 41641200)
21. Chauty A, Ardant MF, Adeye A, Euverte H, Guédénon A, Johnson C, Aubry J, Nuermberger E, Grosset J, 2007. Promising clinical efficacy of streptomycin-rifampin combination for treatment of buruli ulcer (Mycobacterium ulcerans disease). Antimicrob Agents 51: 4029-4035. (Pubitemid 350057802)
22. Debacker M, Aguiar J, Steunou C, Zinsou C, Meyers WM, Portaels F, 2005. Buruli ulcer recurrence, Benin. Emerg Infect Dis 11: 584-589.
23. Kanga JM, Kacou DE, Sangaré A, Dabila Y, Asse NH, Djakeaux S, 2003. [Recurrence cases observed after surgical treatment of Buruli ulcer in Cote d'Ivoire]. Bull Soc Pathol Exot 96: 406-409.
24. Teelken MA, Stienstra Y, Ellen DE, Quarshie E, Klutse E, van der Graaf WT, van der Werf TS, 2003. Buruli ulcer: differences in treatment outcome between two centres in Ghana. Acta Trop 88: 51-56. (Pubitemid 37013336)
25. Amofah G, Asamoah S, Afram-Gyening C, 1998. Effectiveness of excision of preulcerative Buruli lesions in field situations in a rural district in Ghana. Trop Doct 28: 81-83. (Pubitemid 28186609)
26. World Health Organization, 2004. Buruli ulcer disease. Wkly Epidemiol Rec 79: 145-149.
27. World Health Organization, 2006. Buruli ulcer: a manual on how to prevent disability. Available at: http://www.who.int/buruli/information/publications/ pod/en/index.html. Accessed August 26, 2008.
28. Asiedu K, Etuaful S, 1998. Socioeconomic implications of Buruli ulcer in Ghana: a three-year review. Am J Trop Med Hyg 59: 1015-1022. (Pubitemid 29028938)
29. Ellen DE, Stienstra Y, Teelken MA, Dijkstra PU, van der Graaf WT, van der Werf TS, 2003. Assessment of functional limitations caused by Mycobacterium ulcerans infection: towards a Buruli ulcer functional limitation score. Trop Med Int Health 8: 90-96. (Pubitemid 36157319)
30. Phanzu DM, Bafende EA, Dunda BK, Imposo DB, Kibadi AK, Nsiangana SZ, Singa JN, Meyers WM, Suykerbuyk P, Portaels F, 2006. Mycobacterium ulcerans disease (Buruli ulcer) in a rural hospital in Bas-Congo, Democratic Republic of Congo, 2002-2004. Am J Trop Med Hyg 75: 311-314. (Pubitemid 46941351)